The store will not work correctly when cookies are disabled.
5-((1,3-diphenyl-1H-pyrazol-4-yl)methylene)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
ID: ALA4553529
PubChem CID: 1049190
Max Phase: Preclinical
Molecular Formula: C20H14N4O2S
Molecular Weight: 374.43
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1NC(=S)NC(=O)C1=Cc1cn(-c2ccccc2)nc1-c1ccccc1
Standard InChI: InChI=1S/C20H14N4O2S/c25-18-16(19(26)22-20(27)21-18)11-14-12-24(15-9-5-2-6-10-15)23-17(14)13-7-3-1-4-8-13/h1-12H,(H2,21,22,25,26,27)
Standard InChI Key: ARYGXQSEHZQHMK-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
29.5434 -4.2340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3684 -4.2340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6251 -3.4499 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.9559 -2.9632 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.2908 -3.4499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6885 -5.6556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3477 -6.4113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8282 -7.0776 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.6496 -6.9966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9882 -6.2432 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.5055 -5.5709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8437 -4.8184 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.5270 -6.4943 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.1312 -7.6664 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
29.2055 -4.9866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4102 -3.1960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0202 -3.7528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8046 -3.4995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9778 -2.6920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3606 -2.1383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5786 -2.3945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5061 -3.1953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3392 -2.3898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5553 -2.1352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9414 -2.6878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1169 -3.4983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9005 -3.7492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 2 0
5 1 1 0
6 7 1 0
6 11 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
7 13 2 0
9 14 2 0
6 15 2 0
15 1 1 0
3 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
5 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 374.43 | Molecular Weight (Monoisotopic): 374.0837 | AlogP: 2.45 | #Rotatable Bonds: 3 |
Polar Surface Area: 76.02 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.44 | CX Basic pKa: 1.29 | CX LogP: 3.79 | CX LogD: 3.51 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.42 | Np Likeness Score: -1.66 |
References
1. (2012) Entpd5 inhibitors, |